{"rewrite":{"id":"r_f5e98f896384ef8d1b240135","clusterId":"c_2c06b10e2a2349cfc59a0037","slug":"shionogi-launches-japan-s-first-adhd-treatment-support-app-endeavorride","model":"deepseek-v4-flash","headline":"Shionogi Launches Japan's First ADHD Treatment Support App ENDEAVORRIDE","summary":"Shionogi \u0026 Co. released the mobile app ENDEAVORRIDE on June 5, a game designed to support childhood ADHD treatment. It is Japan's first app approved as a medical device program for ADHD. A clinical trial showed statistically significant improvement at six weeks, leading to its approval.","whyItMatters":"The app represents a new category of digital therapeutics in Japan, offering a clinically tested, insurance-covered game-based option for pediatric ADHD treatment.","webCardHtml":"\u003cp\u003eShionogi \u0026 Co. released ENDEAVORRIDE on June 5, a mobile game that functions as a digital therapeutic support app for childhood ADHD. The app is Japan's first to be approved as a medical device program for ADHD treatment. It uses a dual-task mechanic-players tilt their device to steer a character while tapping creatures to collect them-designed to activate the prefrontal cortex and reduce inattention, hyperactivity, and impulsivity. A clinical trial of 164 pediatric patients aged 6-17 found that those using ENDEAVORRIDE showed statistically significant improvement at six weeks compared to those receiving standard treatment. The app is available on iOS and requires an activation code from a medical institution.\u003c/p\u003e","blueskyPost":"Shionogi released ENDEAVORRIDE, Japan's first ADHD treatment support app approved as a medical device. A clinical trial showed improvement at six weeks. Available on iOS with a prescription code.","twitterPost":"Shionogi released ENDEAVORRIDE, Japan's first ADHD treatment support app approved as a medical device. A clinical trial showed improvement at six weeks. Available on iOS with a prescription code.","threadsPost":null,"newsletterBlurb":"Shionogi released ENDEAVORRIDE, a mobile game approved as Japan's first ADHD treatment support app for children. A clinical trial showed statistically significant improvement at six weeks. The app is available on iOS with a medical institution activation code.","attributionJson":"[{\"source\":\"Automaton\",\"url\":\"https://automaton-media.com/articles/newsjp/20260605-447405/\",\"title\":\"Japan's First \\\"Treatment Support App for ADHD\\\" Launches. Shionogi's Clinically Tested \\\"Insurance-Covered\\\" Game\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":3898,"outputTokens":521,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1780653745,"createdAt":"2026-06-05T09:57:22.000Z","publishedAt":"2026-06-05T10:01:21.000Z","updatedAt":"2026-06-05T10:01:21.000Z"},"cluster":{"id":"c_2c06b10e2a2349cfc59a0037","canonicalTitle":"国内初「ADHD用治療補助アプリ」登場。塩野義製薬発、臨床試験済みの“保険適用”ゲーム","representativeArticleId":"a_d43bd74b94a927733aa3a82c","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[\"ENDEAVORRIDE\"],\"studios\":[],\"people\":[],\"type\":\"release\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-06-05T09:15:24.000Z","lastSeenAt":"2026-06-05T09:15:24.000Z","updatedAt":"2026-06-05T10:01:21.000Z"},"attribution":[{"source":"Automaton","url":"https://automaton-media.com/articles/newsjp/20260605-447405/","title":"国内初「ADHD用治療補助アプリ」登場。塩野義製薬発、臨床試験済みの“保険適用”ゲーム"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":["ENDEAVORRIDE"],"studios":[],"people":[],"type":"release","domain":"other","is_roundup":false},"keyFacts":["Shionogi \u0026 Co. released ENDEAVORRIDE on June 5, a mobile game that functions as a digital therapeutic support app for childhood ADHD.","ENDEAVORRIDE is Japan's first app approved as a medical device program for ADHD treatment.","A clinical trial of 164 pediatric patients aged 6-17 found that those using ENDEAVORRIDE showed statistically significant improvement at six weeks compared to standard treatment.","The app uses a dual-task mechanic designed to activate the prefrontal cortex and reduce inattention, hyperactivity, and impulsivity.","ENDEAVORRIDE is available on iOS and requires an activation code from a medical institution."]}